Diabetic macular edema: towards therapy aimed at the underlying pathogenic mechanisms.
Averbukh
Edward
E
Banin
Eyal
E
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D003930:Diabetic Retinopathy / Q000150:complications / Q000188:drug therapy*; D005584:Fovea Centralis / Q000187:drug effects / Q000503:physiopathology; D005938:Glucocorticoids / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D007267:Injections; D008269:Macular Edema / Q000188:drug therapy* / Q000209:etiology; D014222:Triamcinolone Acetonide / Q000008:administration & dosage* / Q000627:therapeutic use; D014822:Vitreous Body
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D014222:Triamcinolone Acetonide